Gainers
• Hepion Pharmaceuticals, Inc. HEPA stock increased by 34.7% to $6.71 during Wednesday's pre-market session. The most recent rating by Brookline Capital, on November 22, is at Buy, with a price target of $12.00.
• CytoSorbents, Inc. CTSO shares increased by 19.5% to $5.63.
• Conatus Pharmaceuticals, Inc. CNAT stock rose 19.0% to $0.49.
• Agile Therapeutics, Inc. AGRX stock rose 7.7% to $4.22.
• Miragen Therapeutics, Inc. MGEN stock moved upwards by 7.0% to $1.69. The most recent rating by Baird, on December 12, is at Neutral, with a price target of $1.00.
• Sorrento Therapeutics, Inc. SRNE stock surged 6.4% to $4.31.
• Inovio Pharmaceuticals, Inc. INO stock rose 4.8% to $4.57. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.
• Co-Diagnostics, Inc. CODX stock moved upwards by 4.2% to $2.70.
Losers
• Avinger, Inc. AVGR shares fell 19.2% to $0.70 during Wednesday's pre-market session.
• Denali Therapeutics, Inc. DNLI shares decreased by 4.5% to $23.72. The most recent rating by Goldman Sachs, on January 27, is at Buy, with a price target of $37.00.
• NantHealth, Inc. NH stock declined 3.9% to $1.97.
• Titan Pharmaceuticals, Inc. TTNP shares plummeted 3.5% to $0.28.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.